于鹏丽,张 婕,闻宝杰.超声弹性应变率比值对BI-RADS 4级乳腺肿块良恶性诊断价值的分析[J].肿瘤学杂志,2016,22(6):439-442.
超声弹性应变率比值对BI-RADS 4级乳腺肿块良恶性诊断价值的分析
Ultrasonic Elastic Strain Rate Ratio in Differential Diagnosis of BI-RADS 4 Breast Lesions
投稿时间:2016-02-16  
DOI:10.11735/j.issn.1671-170X.2016.06.B001
中文关键词:  超声弹性成像  SR  乳腺肿块  BI-RADS
英文关键词:ultrasonic elastography  SR  breast lesions  BI-RADS
基金项目:
作者单位
于鹏丽 南京大学医学院附属鼓楼医院 
张 婕 南京大学医学院附属鼓楼医院 
闻宝杰 南京大学医学院附属鼓楼医院 
摘要点击次数: 2242
全文下载次数: 1069
中文摘要:
      摘 要:[目的] 探讨超声弹性成像应变率比值对BI-RADS 4级乳腺肿块良恶性的诊断价值。[方法] 对182例(共208个肿块)BI-RADS 4级乳腺肿块行超声弹性成像检查,与病理对照,绘制ROC 曲线确定弹性应变率比值最佳鉴别诊断界值。并分析弹性应变率比值在BI-RADS 4A、4B、4C三类中的应用价值。[结果] 弹性应变率比值最佳界值为0.495。弹性应变率比值在BI-RADS 4A类中差异无统计学意义,在BI-RADS 4B、4C类中差异具有统计学意义。弹性成像应变率比值鉴别诊断4B和4C类的灵敏度、特异性、准确性、阳性预测值分别为89.1%、77.3%、88.2%、92.0%和86.3%、80.1%、83.5%、93.3%。[结论] 对于BI-RADS 4B、4C类,联合应用BI-RADS分级系统与弹性成像应变率比值具有较高的应用价值,提示恶性病灶可早期进行手术治疗;对于BI-RADS 4A类,弹性应变率应用价值有限。
英文摘要:
      Abstract:[Objective] To assess the diagnostic value of ultrasonic elastic strain rate ratio for BI-RADS 4 breast lesions.[Methods] One hundred and eighty two patients with 208 BI-RADS 4 breast tumors(137 benign lesions and 71 malignant lesions),underwent ultrasound elastography examination. With pathologic results as the reference standard,the receiver-operating characteristic curve(ROC) was used to identify the cut-off point for differential diagnosis of breast lesions. The application value of strain ratio in the BI-RADS 4A,4B and 4C three levels was analyzed. [Results] There were significant differences in ultrasonic elastic strain rate ratio between malignant and benign lesions in BI-RADS 4B and 4C breast tumors,but no difference in BI-RADS 4A tumors. Taking strain ratio of 0.495 as cut-off value,the sensitivity,specificity,accuracy and positive predictive value for differential diagnosis of malignant from benign tumors in groups BI-RADS 4B and 4C were 89.1%,77.3%,88.2%,92.0% and 86.3%,80.1%,83.5%,93.3% respectively. [Conclusions] The combination of BI-RADS classification and strain ratio may effectively differentiate the malignant nodules from the benign ones in BI-RADS 4B and 4C breast tumors;however,it is not applicable for BI-RADS 4A tumors.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器